Allogeneic versus autologous cell sources present trade-offs in availability, cost, immune risk

https://spark-wiki.win/index.php/Stem_Cell_Therapy_for_Plantar_Fasciitis:_Can_It_Help%3F

Allogeneic versus autologous cell sources present trade-offs in availability, cost, immune risk, and standardization that shape clinical strategy and manufacturing.